CJA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Right arrow Submit a scholarly reply
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nozaki-Taguchi, N.
Right arrow Articles by Taguchi, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nozaki-Taguchi, N.
Right arrow Articles by Taguchi, N.

Canadian Journal of Anesthesia, Vol 42, 685-690, Copyright © 1995 by Canadian Anesthesiologists' Society

ARTICLES

Upper airway obstruction during midazolam sedation: modification by nasal CPAP

N Nozaki-Taguchi, S Isono, T Nishino, T Numai and N Taguchi
Department of Anaesthesia, Funabashi Municipal Medical Centre, Japan.

We examined the depressant effect of midazolam on respiration in 21 healthy women undergoing lower abdominal surgery with spinal anaesthesia. Airway gas flow, airway pressure, and the sound of snoring were recorded together with arterial oxygen saturation (SpO2). After spinal anaesthesia was established, subjects were deeply sedated with pentazocine 15 mg followed by incremental doses of midazolam 1 mg i.v. up to 0.1 mg.kg-1. When SpO2 decreased to < 90% or snoring and/or apnoea was observed, continuous positive airway pressure applied through the nose (nasal CPAP) was increased until the respiratory deterioration was reversed. While one patient remained free of respiratory events, the other 20 patients were successfully treated with nasal CPAP restoring normal SpO2 (95.5 +/- 1.7%) without snoring. Stepwise reduction of nasal CPAP determined the minimally effective CPAP to prevent snoring to be 5.1 +/- 2.1 cm H2O. Further reduction of nasal CPAP induced snoring in 15 patients and obstructive apnoea in five patients with the latter accompanied by a severe reduction of SpO2 (87.4 +/- 6.1%). Patients with apnoea were older than those who snored (P < 0.05. We conclude that upper airway obstruction contributes considerably to decreases in SpO2 during midazolam sedation for spinal anaesthesia.


This article has been cited by other articles:


Home page
 Br J AnaesthHome page
J. L. Bourgain, V. Billard, and A. M. Cros
Pressure support ventilation during fibreoptic intubation under propofol anaesthesia
Br. J. Anaesth., January 1, 2007; 98(1): 136 - 140.
[Abstract] [Full Text] [PDF]

Home page
 Br J AnaesthHome page
D. R. Hillman, P. R. Platt, and P. R. Eastwood
The upper airway during anaesthesia
Br. J. Anaesth., July 1, 2003; 91(1): 31 - 39.
[Abstract] [Full Text] [PDF]

Home page
 Br J AnaesthHome page
J. P. Adams and P. G. Murphy
Obesity in anaesthesia and intensive care
Br. J. Anaesth., July 1, 2000; 85(1): 91 - 108.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1995 by the Canadian Anesthesiologists' Society.